Clinical Trial

Nintedanib With or Without Dextromethorphan in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Name: Nintedanib With or Without Dextromethorphan in Patients With Idiopathic Pulmonary Fibrosis (IPF) — clinical trial record (NCT07583589)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

Nintedanib combined with or without Dextromethorphan for the treatment of IPF, with FVC as the primary efficacy endpoint to evaluate its effectivenes.

Trial Details

NCT Number	NCT07583589
Lead Sponsor	First Affiliated Hospital of Wenzhou Medical University
Conditions	Idiopathic Pulmonary Fibrosis (IPF)
Enrollment	60 participants
Start Date	2026-05-12
Primary Completion	2027-03-01 (estimated)
Study Completion	2027-06-01 (estimated)
Updated on ClinicalTrials.gov	2026-05-13